EPCAM and hepatocellular carcinoma: Zhang and his colleagues [82] prepared an anti-EpCAM bispecific T cell engager (BiTE) 1H8/CD3 which was derived from 1H8 (an anti-EpCAM monoclonal antibody) and was used to treat HCC in vitro and in vivo.